Gist Weekly Newsletter
Gist Weekly: October 9, 2026

In the News
What happened in healthcare recently—and what we think about it.
The next wave of price transparency. The Federal Trade Commission (FTC) Monday sent warning letters to 24 healthcare organizations, reminding them of their obligations to provide “timely, accurate, and complete pricing information” and cautioning that certain disclosure practices could violate federal consumer protection laws, even if they comply with existing Centers for Medicare & Medicaid Services (CMS) requirements. Also on Monday, CMS announced its Transparency in Coverage Final Rule, which it said would improve accuracy and usability of pricing data, expand out-of-network disclosures, modify certain reporting-period requirements, and require personalized cost sharing information by phone. Along with the Final Rule, plans were announced establishing a timeline for development of payer prescription drug pricing files beginning November 2026.
- The Gist: Price transparency has been a major priority for successive presidential administrations for more than a decade, since passage of the Affordable Care Act. “And the pressure for more transparency isn’t going away,” says Joyjit Choudhury, managing director at Kaufman Hall. While healthcare organizations have worked hard to comply with increasing reporting requirements since 2019, the latest FTC warnings and CMS rule underscore the work still needed to make price data useful for patients. The data do have some utility for hospitals and payers, Choudhury says, as they inform pricing and negotiation strategies. “The data have been helpful between payers and providers in navigating their negotiations and relationships with each other, and it is increasingly becoming table stakes to have done your homework on the transparency data before you walk into a negotiation,” he adds. Publicly available pricing data is “definitely changing how negotiations happen,” he says.
And—what we’re following.
- Health systems are beginning to learn how to manage a new expense: AI tokens.
- Pennsylvania announced its fifth measles-related death as cases surpassed 943 in 39 counties; meanwhile, across the state line, New York Gov. Kathy Hochul declared a statewide health emergency as rural measles cases increased dangerously.
Plus—what we’ve been reading.
When the next bed isn’t there. A recent article in The New York Times, published last month, describes a looming mismatch: nursing-home beds are disappearing just as the oldest baby boomers enter their 80s, when the need for skilled nursing and long-term care rises. Closures, staffing shortages, low reimbursement, and financial strain are shrinking capacity in communities across the country. In New York state, for example, 24 nursing homes have closed since 2020, eliminating more than 3,000 licensed beds. Even the term “available” can be misleading: some licensed beds are not operating because facilities lack sufficient staff, while others are effectively out of reach for patients who can’t pay privately. As demand grows, researchers warn, more families may face long searches, distant placements, or no realistic option when a loved one needs post-acute or long-term care.
- The Gist: The result is a mounting capacity challenge that will be felt by aging Americans and by the institutions caring for them. Health systems inherit a problem they did not create, while patients and their families see a failure in a system that isn’t built around their needs. When patients are ready for discharge but there is nowhere safe to send them, they occupy beds that other patients need, creating a bottleneck that angers patients and squeezes hospitals. Because post-acute capacity so directly affects bed availability and patient flow, it becomes a key part of a hospital’s core operating strategy. That may require stronger relationships with skilled-nursing facilities, reserved capacity for complex patients, or expanded hospital-at-home and home-health programs. Hospitals can’t simply acquire their way out of the problem; they need dependable access and aligned incentives with strategic partners equipped to care for the patients who are hardest to place to solve it. Health systems are accustomed to encountering capacity issues, but the next bed they need may be outside the hospital entirely.
Graphic of the Week
A key insight illustrated in infographic form.
Adult women have delayed needed care due to cost
_@2x.png)
Nearly one-third of women say healthcare costs has forced them to make difficult trade-offs, according to the latest KFF Women’s Health Survey. The survey found that 32% of women have skipped filling a needed prescription and 25% have spent less on essentials such as food and electricity to afford care. Women in fair or poor health were more likely to delay care because of cost, with more than half reporting that they had done so. Although Medicaid-covered women delayed less care because of cost than uninsured women and those with individual or employer-sponsored coverage, nearly one-fifth of women reported being currently or previously uninsured. Delayed care can increase the complexity and cost of treatment, worsen outcomes, and make it more difficult for hospitals and health systems to manage patients effectively.
This Week at Kaufman Hall
Hospitals face growing pressure from inflation, labor costs, and other external forces that threaten already-thin margins. In this new blog, Ken Kaufman and Erik Swanson explain how leaders can distinguish the challenges they cannot control from the conditions they can address. They outline practical steps for making more informed decisions based on each organization’s specific financial position and operating environment.
On Our Podcast
The Gist Healthcare Podcast—all the headlines in healthcare policy, business and more, in 10 minutes or less every other weekday morning.
Earlier this week, we heard the conclusion of host J. Carlisle Larsen's encore conversation with Colleen Fogarty, M.D., about how the loss of family physicians impacts rural communities.
This Monday, JC speaks with Heather Landi from Fierce Healthcare about Utah's recent expansion of its AI regulatory sandbox to include more clinical applications. They talk more about what companies are included and more clinical oversight that the state has baked into these pilots.
Thanks for reading! Please check out our Gist Weekly archive for past editions. We also have all our recent Graphics of the Week available here.
Best regards,
The Gist Weekly team at Kaufman Hall